NSE filing, NSE: THELEELA. Summary written from the filing by ALFA Finder's alert engine.
Leela Palaces Hotels & Resorts Ltd: key numbers
- Share price
- ₹689.75
- Market cap
- ₹23,035 Cr
- Revenue (annual)
- ₹1,527 Cr
- Net profit (annual)
- ₹403.1 Cr
- P/E (TTM)
- 49.8×Sector 46.7×
- Promoter holding
- 75.91%+0.00% QoQ
- FII holding
- 7.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Leela Palaces Hotels & Resorts Ltd
All →Leela Palaces Hotels & Resorts Annual General Meeting
Company seeks shareholder approval via postal ballot for material related party transactions with Leela BKC Holdings Private Limited. The voting period ends on November 15, 2026.
Leela Palaces Hotels & Resorts Earnings Call Transcript: Key Takeaways
Leela delivered a high-quality quarter, leveraging the BRICS summit and rising luxury demand to expand margins through significant premiumization.
Leela Palaces Hotels & Resorts Other Announcement
ICRA's Q2 FY2027 Monitoring Agency Report confirms Leela Palaces' IPO proceeds utilization aligns with stated objects. No deviations were observed for the quarter ended September 2026.
Leela Palaces Hotels & Resorts Investor Presentation: Key Takeaways
The Leela delivered a strong Q2FY27 with 33% operating revenue growth and 36% EBITDA growth. Strategy focuses on luxury scaling, asset-light management, and high-profile event premiumization.
Leela Palaces Hotels & Resorts Results Update
Leela Palaces Q2 FY27 revenue grew 33% to ₹4,119 Cr; EBITDA rose 36% to ₹1,877 Cr. PAT up 27% to ₹946 Cr on record ADR growth.
Leela Palaces Hotels & Resorts Q2 FY27 Results: Net Profit ₹94.6 Cr, Up 26.6% YoY
Leela Palaces Hotels & Resorts Ltd reported revenue from operations of ₹411.9 Cr (+32.6% YoY) and net profit of ₹94.6 Cr (+26.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹94.6 Cr · +26.6% YoY
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.